According to a report from Marca, a €50m offer could be enough for the Reds to sign Eduardo Camavinga from Real Madrid. The suggestion immediately raises important questions about Liverpool’s squad ...

Reported accuracies were 86% (Random Forest) and 96% (convolutional neural networks), positioning retinal imaging as a candidate scalable tool for underserved populations. AI-powered polarized-light ...

Finally, a win for the Ateneo Blue Eagles. The Blue Eagles are winless no more after sweeping the University of the East Lady Warriors, 25-19, 25-23, 25-16, in their UAAP Season 88 women’s volleyball ...

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

The posts highlight the phone's primary and telephoto camera, which uses the 200MP Sony LYT-901 and 200MP Samsung ISOCELL HPO ...

vivo has been on a bit of a roll recently with flagships like the X300 Pro... The post vivo Y51 Pro 5G Launched in India With 7,200mAh Battery, Dimensity 7360 Turbo appeared first on Fossbytes.

To better understand how microplastics move through the body, researchers at Tokyo University of Science, Japan, have developed fluorescent nano-sized microplastics that can be tracked in real time ...

NEW YORK – T-Knife Therapeutics plans to begin a clinical trial this year of its PRAME-targeting armored T cell receptor (TCR) therapy, after the company confirmed on Tuesday that the European ...

Metagenomi Therapeutics, Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The Company was founded on the ...

The Vivo Energy Investments B.V.-Bond has a maturity date of 9/24/2027 and offers a coupon of 5.1250%. The payment of the coupon will take place 2,0 times per biannual on the 24.03.. At the current ...